Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages-Reference-Cited by-同舟云学术

Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages

Published:2017-04 Issue:4 Volume:222 Page:651-657
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Jiang Canhua,Yuan Fulai,Wang Jie,Wu Limeng

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference32 articles.

1. The cell biology of macrophage activation;Adams;Annu. Rev. Immunol.,1984

2. Salivary immunosuppressive cytokines IL-10 and IL-13 are significantly elevated in oral squamous cell carcinoma patients;Aziz;Cancer Invest.,2015

3. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm;Biswas;Nat. Immunol.,2010

4. Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages;Bloch;Clin. Cancer Res.,2013

5. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule;Falini;Am. J. Pathol.,1993

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4;Pharmacological Reviews;2024-03-04

2. Hyperthermia in Combination with Emerging Targeted and Immunotherapies as a New Approach in Cancer Treatment;Cancers;2024-01-24

3. The expression mechanism of programmed cell death 1 ligand 1 and its role in immunomodulatory ability of mesenchymal stem cells;Chinese Journal of Traumatology;2024-01

4. Oral squamous cell carcinomas: state of the field and emerging directions;International Journal of Oral Science;2023-09-22

5. Regulation of programmed death ligand 1 expression by interferon‐γ and tumour necrosis factor‐α in canine tumour cell lines;Veterinary and Comparative Oncology;2023-03-08